Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $17.0 million.

  • LifeStance Health's Free Cash Flow fell 381.98% to $17.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.4 million, marking a year-over-year increase of 24053.62%. This contributed to the annual value of $85.7 million for FY2024, which is 24928.23% up from last year.
  • As of Q3 2025, LifeStance Health's Free Cash Flow stood at $17.0 million, which was down 381.98% from $56.6 million recorded in Q2 2025.
  • Over the past 5 years, LifeStance Health's Free Cash Flow peaked at $56.6 million during Q2 2025, and registered a low of -$35.2 million during Q3 2023.
  • Its 5-year average for Free Cash Flow is $3.3 million, with a median of -$8.0 million in 2021.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 199914.68% in 2022, then skyrocketed by 94097.75% in 2024.
  • Over the past 5 years, LifeStance Health's Free Cash Flow (Quarter) stood at -$8.0 million in 2021, then surged by 417.51% to $25.5 million in 2022, then plummeted by 78.93% to $5.4 million in 2023, then surged by 940.98% to $56.0 million in 2024, then tumbled by 69.66% to $17.0 million in 2025.
  • Its last three reported values are $17.0 million in Q3 2025, $56.6 million for Q2 2025, and -$10.3 million during Q1 2025.